Latest News about Pfizer
Recent news which mentions Pfizer
Sickle-cell Anemia Therapeutics Market Research & Clinical Advancements by 2028 | Addmedica, Gamida Cell, GlycoMimetics
January 07, 2021
Tags
Bluebird Bio
Sickle/cell Anemia Therapeutics market in Australia
Sickle/cell Anemia Therapeutics market SWOT analysis
From X herald
'Making Progress': Stock Market Update For The Week Ahead
December 21, 2020
From Benzinga
FDA authorizes Moderna’s COVID-19 vaccine for emergency use
December 18, 2020
Tickers
TC
From TechCrunch
Fintech Focus For December 17, 2020
December 16, 2020
From Benzinga
Fintech Focus For December 14, 2020
December 13, 2020
From Benzinga
'Liquidity Jumping': Stock Market Update For The Week Ahead
December 13, 2020
From Benzinga
FDA grants emergency use authorization for Pfizer’s COVID-19 vaccine, distribution to begin within days
December 11, 2020
Tickers
TC
From TechCrunch
FDA panel recommends approving Pfizer’s COVID-19 vaccine emergency use authorization
December 10, 2020
Tickers
TC
From TechCrunch
Stock ETFs Rally Amid Pfizer Vaccine Rollout Enthusiasm
December 08, 2020
From ETF Trends
'The Third Wave': Stock Market Update For The Week Ahead
December 06, 2020
From Benzinga
Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace
December 06, 2020
From Benzinga
Fintech Focus For December 4, 2020
December 03, 2020
From Benzinga
As U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to Rally
December 03, 2020
From ETF Trends
Moderna claims 94% efficacy for COVID-19 vaccine, will ask FDA for emergency use authorization today
November 30, 2020
Tickers
TC
From TechCrunch
Biotech ETFs Remain Hot As Investors Await Upcoming Vaccine
November 27, 2020
From ETF Trends
AstraZeneca says it will likely do another study of COVID-19 vaccine after accidental lower dose shows higher efficacy
November 26, 2020
From TechCrunch
Fintech Focus For November 24, 2020
November 23, 2020
From Benzinga
How One Contractor Is Trying To Help Detroit Recover From The Pandemic
November 23, 2020
Tickers
PFE
From Benzinga
Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store
November 23, 2020
Tickers
TC
From TechCrunch
'Litmus Test': Stock Market Update For The Week Ahead
November 22, 2020
From Benzinga
Barron's Picks And Pans: Emerging Markets, Kandi, Simon Property, Plug Power And More
November 21, 2020
From Benzinga
Pfizer and BioNTech to submit request for emergency use approval of their COVID-19 vaccine today
November 20, 2020
Tickers
TC
From TechCrunch
Fintech Focus For November 19, 2020
November 18, 2020
From Benzinga
Pfizer says its COVID-19 vaccine is 95% effective in final clinical trial results analysis
November 18, 2020
Tickers
TC
From TechCrunch
Biotech ETFs Poised for Gains after Moderna Vaccine News
November 16, 2020
From ETF Trends
Moderna reports its COVID-19 vaccine is 94.5% effective in first data from Phase 3 trial
November 16, 2020
Tickers
TC
From TechCrunch
'Upside Surprise': Stock Market Update For The Week Ahead
November 15, 2020
From Benzinga
Fintech Focus Roundup For November 14, 2020
November 14, 2020
From Benzinga
Fintech Focus For November 12, 2020
November 11, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.